Ajay Kumar/LinkedIn
Mar 2, 2026, 16:09
Ajay Kumar: The Progression of HDFN – From Fetal Anemia to Kernicterus
Ajay Kumar, Senior Resident at Geetanjali Hospital, shared a post on LinkedIn:
“As a transfusion medicine specialist, I often emphasize the importance of early Antibody Screening in pregnancy.
Haemolytic Disease of the Fetus and Newborn (HDFN) is a preventable yet potentially life-threatening condition.
Timely antenatal antibody screening, appropriate monitoring, and interventions like intrauterine transfusion (IUT) or phototherapy can save lives and prevent permanent neurological damage.
Prevention and vigilance remain our strongest tools.”
Stay updated with Hemostasis Today.
-
Jun 2, 2026, 15:28Kabilan K. L.: Management and Diagnosis of Acute Coronary Syndrome Types
-
Jun 2, 2026, 15:26Mital Jhaveri: What New Data Reveal About DOACs and Androgen Receptor Inhibitors?
-
Jun 2, 2026, 15:22Dhananjaya Kotebagilu Narayana Vamyanmane: High-Resolution Ultrasound Evaluation of Bowel Wall Ischemia
-
Jun 2, 2026, 15:20Joep Schellens: Influence of Dexamethasone and Tocilizumab on Fibrinolysis in COVID-19
-
Jun 2, 2026, 15:12Ebrahim Umer: The Sickest Liver Patients Deserve One Language – Lessons from the Kyoto Consensus
-
Jun 2, 2026, 15:10Ney Carter Borges: Bempedoic Acid and Venous Thromboembolism Risk in Statin-Intolerant Patients
-
Jun 2, 2026, 15:07Sayan Koley: Coagulation Science – Where Precision Saves Lives
-
Jun 2, 2026, 15:04Ahmed Mohsen: Low CHA₂DS₂-VA Score Does Not Always Mean No Anticoagulation
-
Jun 2, 2026, 15:04The Risk Factors and Optimal Prevention Strategies of VTE in Sickle Cell Disease – RPTH Journal